Home
Research
GloBody
Members
Publications
Links
Book Club
Press Coverage
Guest Lectures
Contact
More
april 2025
COVID-19 exposure risks and protective measures in East London’s healthcare and academic sectors: Insights and applications of GloBody technology for infectious disease monitoring
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspective
june 2024
Immunogenicity of biologics used in the treatment of asthma
May 2024
Eukaryotic ribosome display for antibody discovery: A review
Dec 2023
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis
July 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
MARCH 2023
Exploring the “N-Terminal Anchor” Binding Interface of the T3SS Chaperone–Translocator Complexes from P. aeruginosa
JUNE 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
december 2021
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS